Topic
Vascellum
About: Vascellum is a research topic. Over the lifetime, 5 publications have been published within this topic receiving 51 citations.
Papers
Patent•
12 Nov 2008
TL;DR: In this paper, a dynamic model directed angiography 3D reconstruction method is proposed to assist detection and surgery guidance for cardiovascular disease in clinical medicine, which can effectively assist clinical requests.
Abstract: The present invention provides a dynamic model directed angiography three-dimensional reconstruction method, pertaining to an intersectional field of digital image processing and medicine imaging, for satisfying special requests of auxiliary detection and surgery guidance for cardiovascular disease in clinical medicine. The invention includes steps of angiography image preprocessing, vascellum segmentation, vascellum skeleton and radii extraction, model directed vascellum base element recognition, vascellum matching and vascellum three-dimensional reconstruction. The invention also provides a cardiovascular dynamic model construction method including steps of cardiovascular slice data extraction, cordis static and dynamic model building, and static and dynamic model building. According to the invention, good angiography three-dimensional reconstruction result may be obtained, which effectively assists detection and surgery guidance for cardiovascular disease, thereby satisfying clinical requests.
31 citations
1 Jan 1970
10 citations
Patent•
12 Jun 2007
TL;DR: A degradable anastomotic cannula of vascellum, which is a cylindrical cannula made from high molecular material PLLA by an injection molding method, was revealed in this paper.
Abstract: The invention discloses a degradable anastomotic cannula of vascellum, which is a cylindrical cannula made from high molecular material PLLA by an injection moulding method. The wall thickness and internal diameter of the cannula are adaptive to the vascellum to be repaired. The PLLA anastomotic cannula of vascellum prepared by invention has biodegradability so as to solve the problem of remaining of anastomotic devices in vivo. After the completion of anastomosis between the cannula and the vascellum, on the one hand, the cannula can support and fix at a certain time so as to ensure the good anastomosis of the two broken ends of the vascellum and that an ariastomotic stoma is not easy to be distorted and narrowed; on the other hand, the cannula can be automatically and gradually degraded and absorbed in vivo finally. No damage to tunica intima and suture remaining occur in the cavosurface of the vascellum after anastomosis, thus the normal vasomotoricity and growing development of the vascellum are not influenced, and foreign body granuloma does not form on the adventitia of the vascellum, thereby reducing the possibility of the formation of thrombus at the ariastomotic stoma so as to have excellent long-dated patency rate of the vascellum.
6 citations
Patent•
30 Mar 2005
TL;DR: In this article, a may bloom general flavone which can be expected for treating and preventing heart-head vascellum diseases, and its preparation produced by the invention method can be used to treat and prevent coronary disease, stenocardia, myocardial infarction, hypertension, hyperlipemia, arythmia etc.
Abstract: The invention provides may bloom general flavone which can be expected for treating and preventing heart-head vascellum diseases, and the prepn, method The may bloom general flavone and its preparation produced by the invention method can be used to treat and prevent coronary disease, stenocardia, myocardial infarction, hypertension, hyperlipemia, arythmia etc, and retrogressive pathologic changement of heart-head vascellum caused by said diseases
3 citations
Patent•
6 Feb 2008
TL;DR: In this article, the use of specific antagonist of TP recipient in curing vascular disease of patient suffered from cerebrovascular accident in before, in particular, in particularly to use a specific antagonist in medicine used to reduce cerebral ischemia accident and transient ischemic attack (TIA) in before.
Abstract: The invention relates to the use of specific antagonist of TP recipient in curing vascular disease of patient suffered from cerebrovascular accident in before, in particular to the use of specific antagonist of TP recipient in medicine used to reduce cerebrovascular and cardiovascular events of patient suffered from cerebral ischemia accident (CLA) and transient ischemic attack (TIA) in before.
2 citations
Related Topics (5)
Performance Metrics
| Year | Papers |
|---|---|
| 2008 | 2 |
| 2007 | 1 |
| 2005 | 1 |
| 1970 | 1 |